Attacks on health workers in Lebanon reach unprecedented levels

Since 7 October 2023, 47% of attacks on health care – 65 out of 137 – have proven fatal to at least one health worker or patient in Lebanon, as of 21 November 2024.

As weight loss leaders boom, one biotech contender abandons its quest with Chapter 7 liquidation

Weight loss drugs were heralded as one of the biggest innovations in biopharma in 2023, as the GLP-1 contenders swelled into megablockbusters. But for one

November 4, 2023

(Favezelimab + pembrolizumab) by Merck for Bladder Cancer: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

November 5, 2023

Polyploidy can be a double-edged sword in cancer

Polyploidy is a state where a cell contains more copies of the genetic material than the usual “diploid” cell, which contains two copies.

October 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.